Interferon gamma 1b (DrugBank: Interferon Gamma)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 228 | Bronchiolitis obliterans | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01639261 (ClinicalTrials.gov) | July 2012 | 9/7/2012 | A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT | Eine Phase II Studie über Interferon Gamma 1b Zur Behandlung Der steroidrefraktären Bronchiolitis Obliterans Nach Allogener SZT | Steroid-refractory Bronchiolitis Obliterans | Drug: Interferon gamma 1b | University Hospital Regensburg | ClinAssess GmbH | Active, not recruiting | 18 Years | N/A | Both | 10 | Phase 2 | Germany |
| 2 | EUCTR2010-022467-36-DE (EUCTR) | 22/06/2011 | A phase II study about interferon gamma 1b to therapy the steroid-refractory bronchiolitis obliterans after allogenic stem cell therapy | A phase II study about interferon gamma 1b to therapy the steroid-refractory bronchiolitis obliterans after allogenic stem cell therapy | steroid-refractory bronchiolitis obliterans MedDRA version: 13.1;Level: PT;Classification code 10029888;Term: Obliterative bronchiolitis;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Trade Name: Imukin Product Name: Imukin INN or Proposed INN: Interferon gamma-1b Other descriptive name: INTERFERON GAMMA-1B | Freistaat Bayern | NULL | Not Recruiting | Female: yes Male: yes | Phase 2 | Germany |